Philips’ stock price rises after finalizing device sales agreement with U.S.

Philips restated its financial outlook Wednesday after finalizing an agreement with the U.S. Department of Justice and the Food and Drug Administration that would ban sales of new respiratory therapy devices in the U.S. but allow exports.